1st Tech. Review Meeting Agenda
| When | Thursday, October 19th 2017 |
| Location | Euroforum Rue Robert Stumpfer, EUFO 2265A L-2920 Luxembourg |
| Duration | Who | What |
| 00:05 | All | People arriving + setup |
| 00:10 | OBHP | Presentation of consortium and meeting participants |
| 00:10 | OBHP | Intro by Coordinator – general project summary
· overview of most important steps in UL prosthetics · overview of project progress · overview of deliverables and milestones · Amendment of partner change |
| 00:25 | OBG | Liner and electronics + DEMO |
| 00:25 | UMG/ICL | Modelling, Coadaptation + DEMO |
| 00:15 | Coffee Break | |
| 00:25 | UMCG | User training methods * DEMO |
| 00:25 | IDSIA | Recognition Algorithms + DEMO |
| 00:35 | OSS & UMCG | Evaluations |
| 01:00 | Lunch Break | |
| 00:30 | OBHP | Concluding presentation (OBHP):
· Communication · Dissemination · Exploitation plan · IPR situation · Future |
| 01:00 | EC & Reviewers | Reviewers meeting |
| 00:30 | EC & Reviewers | Recommendations and feedback |
Participants INPUT Consortium
| OBHP | |
| Sebastian AMSÜSS | |
| Friedrich RUSSOLD | |
| Markus Schachinger | |
| OBG | |
| Heiko GLINDEMANN | |
| Mario KOPPE | |
| OSS | |
| Andreas KRANZL | |
| SUPSI | |
| Michael WAND | |
| Klaus GREFF | |
| ICL | |
| Dario FARINA | |
| Ivan VUJAKLIJA | |
| UMCG | |
| Corry van der Sluis | |
| Raoul BONGERS | |
| Alessio MURGIA | |
| Andreas FRANZKE | |
| Morton Kristoffersen | |
Reviewer
![]() | ![]() Dr Luc Berthouze Centre for Computational Neuroscience and Robotics Sussex Neuroscience School of Engineering and Informatics | Research expertise: Biomedical Signal Processing Computational Neuroscience Developmental Robotics EEG, EMG Motor Control Network Theory and Complexity Neuronal network Nonlinear Dynamics and Chaos |
![]() | Dr Saso Jezernik Bussiness Director Altran Zurich Leader/Head of CH Innovation Practice | Current position: responsible for a team of business managers, about 50 consultants and support staff in marketing, sourcing / HR and business administration; direct lead of about 35 consultants KAM / GAM of major international pharmaceutical, energy, and medical device companies |
Gallery
![]() |
|
![]() | ![]() |
![]() | ![]() |
![]() | |







